{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:00:55Z","timestamp":1792155655065,"version":"4.4.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Betel nut chewing plays a role in the pathogenesis of oral submucous fibrosis (OSF) and oral squamous cell carcinoma (OSCC). As the major active ingredient of the betel nut, the effect of arecoline and its underlying mechanism to OSF and OSCC pathogenesis remain unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Next-generation sequencing-based transcriptome and dRRBS analysis were performed on OSF and OSCC cells under low-dose arecoline exposure. Functional analyses were performed to compare the different roles of arecoline during OSF and OSCC pathogenesis, and key genes were identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we identified that low-dose arecoline promoted cell proliferation of both NFs and OSCC cells via the acceleration of cell cycle progression, while high-dose arecoline was cytotoxic to both NFs and OSCC cells. We performed for the first time the transcriptome and methylome landscapes of NFs and OSCC cells under low-dose arecoline exposure. We found distinct transcriptome and methylome profiles mediated by low-dose arecoline in OSF and OSCC cells, as well as specific genes and signaling pathways associated with metabolic disorders induced by low-dose arecoline exposure. Additionally, low-dose arecoline displayed different functions at different stages, participating in the modulation of the extracellular matrix via Wnt signaling in NFs and epigenetic regulation in OSCC cells. After exposure to low-dose arecoline, the node roles of <jats:italic>FMOD<\/jats:italic> in NFs and histone gene clusters in OSCC cells were found. Meanwhile, some key methylated genes induced by arecoline were also identified, like <jats:italic>PTPRM<\/jats:italic> and <jats:italic>FOXD3<\/jats:italic> in NFs, <jats:italic>SALL3<\/jats:italic> and <jats:italic>IRF8<\/jats:italic> in OSCC cells, indicating early molecular events mediated by arecoline during OSF and OSCC pathogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study elucidated the contribution of low-dose arecoline to OSF and OSCC pathogenesis and identified key molecular events that could be targeted for further functional studies and their potential as biomarkers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-023-02887-2","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T09:03:38Z","timestamp":1679735018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhenming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoji","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanghui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"issue":"1","key":"2887_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/13556210020091437","volume":"7","author":"PC Gupta","year":"2002","unstructured":"Gupta PC, Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol. 2002;7(1):77\u201383.","journal-title":"Addict Biol"},{"issue":"2","key":"2887_CR2","first-page":"1118","volume":"9","author":"A Auluck","year":"2009","unstructured":"Auluck A, Hislop G, Poh C, Zhang L, Rosin MP. Areca nut and betel quid chewing among South Asian immigrants to Western countries and its implications for oral cancer screening. Rural Remote Health. 2009;9(2):1118.","journal-title":"Rural Remote Health"},{"issue":"4\u20135","key":"2887_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.oraloncology.2008.05.018","volume":"45","author":"S Petti","year":"2009","unstructured":"Petti S. Lifestyle risk factors for oral cancer. Oral Oncol. 2009;45(4\u20135):340\u201350.","journal-title":"Oral Oncol"},{"issue":"8","key":"2887_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042759","volume":"7","author":"RN Sharan","year":"2012","unstructured":"Sharan RN, Mehrotra R, Choudhury Y, Asotra K. Association of betel nut with carcinogenesis: revisit with a clinical perspective. PLoS ONE. 2012;7(8): e42759.","journal-title":"PLoS ONE"},{"issue":"3","key":"2887_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4103\/njms.njms_324_21","volume":"12","author":"T Ahmad","year":"2021","unstructured":"Ahmad T, Khan I, Rizvi MM, Saalim M, Manzoor N, Sultana A. An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis. Natl J Maxillofac Surg. 2021;12(3):316\u201323.","journal-title":"Natl J Maxillofac Surg"},{"issue":"2","key":"2887_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.oooo.2015.11.024","volume":"122","author":"JG Ray","year":"2016","unstructured":"Ray JG, Ranganathan K, Chattopadhyay A. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(2):200\u20139.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"2887_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/jop.12553","volume":"46","author":"AR Gadbail","year":"2017","unstructured":"Gadbail AR, Chaudhary M, Gawande M, Hande A, Sarode S, Tekade SA, Korde S, Zade P, Bhowate R, Borle R, et al. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. J Oral Pathol Med. 2017;46(6):448\u201353.","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"2887_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrc3486","volume":"13","author":"W Timp","year":"2013","unstructured":"Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer. 2013;13(7):497\u2013510.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2887_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00795-020-00265-3","volume":"54","author":"BR Adhikari","year":"2021","unstructured":"Adhikari BR, Yoshida K, Paudel D, Morikawa T, Uehara O, Sato J, Muthumala M, Amaratunga P, Arakawa T, Chiba I, et al. Aberrant expression of DUSP4 is a specific phenomenon in betel quid-related oral cancer. Med Mol Morphol. 2021;54(2):79\u201386.","journal-title":"Med Mol Morphol"},{"key":"2887_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/378358","volume":"2014","author":"ZL Lai","year":"2014","unstructured":"Lai ZL, Tsou YA, Fan SR, Tsai MH, Chen HL, Chang NW, Cheng JC, Chen CM. Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma. Biomed Res Int. 2014;2014: 378358.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2887_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13148-019-0806-y","volume":"12","author":"S Islam","year":"2020","unstructured":"Islam S, Uehara O, Matsuoka H, Kuramitsu Y, Adhikari BR, Hiraki D, Toraya S, Jayawardena A, Saito I, Muthumala M, et al. DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing-a possible predictive biomarker for malignant transformation. Clin Epigenetics. 2020;12(1):12.","journal-title":"Clin Epigenetics"},{"issue":"5","key":"2887_CR12","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3892\/or.2015.4264","volume":"34","author":"S Zhou","year":"2015","unstructured":"Zhou S, Chen L, Mashrah M, Zhu Y, He Z, Hu Y, Xiang T, Yao Z, Guo F, Zhang C. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis. Oncol Rep. 2015;34(5):2636\u201342.","journal-title":"Oncol Rep"},{"key":"2887_CR13","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.2147\/OTT.S91460","volume":"8","author":"S Zhou","year":"2015","unstructured":"Zhou S, Chen L, Mashrah M, Zhu Y, Liu J, Yang X, He Z, Wang L, Xiang T, Yao Z, et al. Deregulation of secreted frizzled-related proteins is associated with aberrant beta-catenin activation in the carcinogenesis of oral submucous fibrosis. Onco Targets Ther. 2015;8:2923\u201331.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"2887_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.taap.2011.06.010","volume":"255","author":"I Saha","year":"2011","unstructured":"Saha I, Chatterjee A, Mondal A, Maiti BR, Chatterji U. Arecoline augments cellular proliferation in the prostate gland of male Wistar rats. Toxicol Appl Pharmacol. 2011;255(2):160\u20138.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"2887_CR15","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1111\/cas.14866","volume":"112","author":"H Ren","year":"2021","unstructured":"Ren H, He G, Lu Z, He Q, Li S, Huang Z, Chen Z, Cao C, Wang A. Arecoline induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression. Cancer Sci. 2021;112(6):2173\u201384.","journal-title":"Cancer Sci"},{"issue":"1","key":"2887_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12860-020-00325-7","volume":"21","author":"Q Chen","year":"2020","unstructured":"Chen Q, Jiao J, Wang Y, Mai Z, Ren J, He S, Li X, Chen Z. Egr-1 mediates low-dose arecoline induced human oral mucosa fibroblast proliferation via transactivation of Wnt5a expression. BMC Mol Cell Biol. 2020;21(1):80.","journal-title":"BMC Mol Cell Biol"},{"issue":"8","key":"2887_CR17","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1349-7006.2008.00863.x","volume":"99","author":"YJ Chen","year":"2008","unstructured":"Chen YJ, Chang JT, Liao CT, Wang HM, Yen TC, Chiu CC, Lu YC, Li HF, Cheng AJ. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci. 2008;99(8):1507\u201314.","journal-title":"Cancer Sci"},{"issue":"2","key":"2887_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1600-0714.1999.tb01998.x","volume":"28","author":"JH Jeng","year":"1999","unstructured":"Jeng JH, Hahn LJ, Lin BR, Hsieh CC, Chan CP, Chang MC. Effects of areca nut, inflorescence piper betle extracts and arecoline on cytotoxicity, total and unscheduled DNA synthesis in cultured gingival keratinocytes. J Oral Pathol Med. 1999;28(2):64\u201371.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"2887_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/13556210120091482","volume":"7","author":"CR Trivedy","year":"2002","unstructured":"Trivedy CR, Craig G, Warnakulasuriya S. The oral health consequences of chewing areca nut. Addict Biol. 2002;7(1):115\u201325.","journal-title":"Addict Biol"},{"issue":"2","key":"2887_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1600-0714.1998.tb02096.x","volume":"27","author":"YC Chang","year":"1998","unstructured":"Chang YC, Tai KW, Cheng MH, Chou LS, Chou MY. Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro. J Oral Pathol Med. 1998;27(2):68\u201371.","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"2887_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0278-6915(99)00050-2","volume":"37","author":"JH Jeng","year":"1999","unstructured":"Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY. Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol. 1999;37(7):751\u20136.","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"2887_CR22","first-page":"161","volume":"21","author":"CL Tsai","year":"1997","unstructured":"Tsai CL, Kuo MY, Hahn LJ, Kuo YS, Yang PJ, Jeng JH. Cytotoxic and cytostatic effects of arecoline on oral mucosal fibroblasts. Proc Natl Sci Counc Repub China B. 1997;21(4):161\u20137.","journal-title":"Proc Natl Sci Counc Repub China B"},{"issue":"4","key":"2887_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.31557\/APJCP.2020.21.4.1005","volume":"21","author":"BA Al-Tayar","year":"2020","unstructured":"Al-Tayar BA, Ahmad A, Yusoff ME, Abdullah SF, Mohamad NK, Md Hashim SN, Kishida S, Kishida M, Nakamura N, Kibe T, et al. Cytotoxic effects of betel quid and areca nut aqueous extracts on mouse fibroblast, human mouth-ordinary-epithelium 1 and human oral squamous cell carcinoma cell lines. Asian Pac J Cancer Prev. 2020;21(4):1005\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"2887_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1600-0714.2009.00881.x","volume":"39","author":"S Cox","year":"2010","unstructured":"Cox S, Vickers ER, Ghu S, Zoellner H. Salivary arecoline levels during areca nut chewing in human volunteers. J Oral Pathol Med. 2010;39(6):465\u20139.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"2887_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4103\/jomfp.JOMFP_143_18","volume":"22","author":"D Venkatesh","year":"2018","unstructured":"Venkatesh D, Puranik RS, Vanaki SS, Puranik SR. Study of salivary arecoline in areca nut chewers. J Oral Maxillofac Pathol. 2018;22(3):446.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"7","key":"2887_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1600-0714.1996.tb00281.x","volume":"25","author":"JH Jeng","year":"1996","unstructured":"Jeng JH, Lan WH, Hahn LJ, Hsieh CC, Kuo MY. Inhibition of the migration, attachment, spreading, growth and collagen synthesis of human gingival fibroblasts by arecoline, a major areca alkaloid, in vitro. J Oral Pathol Med. 1996;25(7):371\u20135.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"2887_CR27","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00784-011-0604-1","volume":"16","author":"SK Tseng","year":"2012","unstructured":"Tseng SK, Chang MC, Su CY, Chi LY, Chang JZ, Tseng WY, Yeung SY, Hsu ML, Jeng JH. Arecoline induced cell cycle arrest, apoptosis, and cytotoxicity to human endothelial cells. Clin Oral Investig. 2012;16(4):1267\u201373.","journal-title":"Clin Oral Investig"},{"issue":"2","key":"2887_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-0714.1997.tb00024.x","volume":"26","author":"J de Waal","year":"1997","unstructured":"de Waal J, Olivier A, van Wyk CW, Maritz JS. The fibroblast population in oral submucous fibrosis. J Oral Pathol Med. 1997;26(2):69\u201374.","journal-title":"J Oral Pathol Med"},{"issue":"Suppl 2","key":"2887_CR29","doi-asserted-by":"publisher","first-page":"S1234","DOI":"10.4103\/jpbs.jpbs_408_21","volume":"13","author":"A Banerjee","year":"2021","unstructured":"Banerjee A, Mampilly MO, Kamath VV, Athreya V, Kotrashetti V, Srivastava KC, Shrivastava D. Phenotypic expression of oral fibroblasts derived from oral submucous fibrosis: an assay through cell culture. J Pharm Bioallied Sci. 2021;13(Suppl 2):S1234\u20139.","journal-title":"J Pharm Bioallied Sci"},{"issue":"6","key":"2887_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415\u201328.","journal-title":"Nat Rev Genet"},{"key":"2887_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-publhealth-040617-014629","volume":"39","author":"EM Martin","year":"2018","unstructured":"Martin EM, Fry RC. Environmental influences on the epigenome: exposure- associated DNA methylation in human populations. Annu Rev Public Health. 2018;39:309\u201333.","journal-title":"Annu Rev Public Health"},{"issue":"2","key":"2887_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1600-0714.2004.00034.x","volume":"33","author":"SC Lin","year":"2004","unstructured":"Lin SC, Liu CJ, Chiu CP, Chang SM, Lu SY, Chen YJ. Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. J Oral Pathol Med. 2004;33(2):79\u201386.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"2887_CR33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.31557\/APJCP.2020.21.4.1115","volume":"21","author":"MA Raffat","year":"2020","unstructured":"Raffat MA, Hadi NI, Alghamdi O, Al-Aali KA, Al Deeb M, Abduljabbar T, Vohra F. Expression of salivary S100A7 levels in stage I oral submucous fibrosis: a clinical and laboratory study. Asian Pac J Cancer Prev. 2020;21(4):1115\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"2887_CR34","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/ijc.28473","volume":"134","author":"J Kaur","year":"2014","unstructured":"Kaur J, Matta A, Kak I, Srivastava G, Assi J, Leong I, Witterick I, Colgan TJ, Macmillan C, Siu KW, et al. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer. 2014;134(6):1379\u201388.","journal-title":"Int J Cancer"},{"issue":"8","key":"2887_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.oraloncology.2008.11.012","volume":"45","author":"MR Kesting","year":"2009","unstructured":"Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, Wolff KD, Wagenpfeil S, Al-Benna S, Jacobsen F, Steinstraesser L. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol. 2009;45(8):731\u20136.","journal-title":"Oral Oncol"},{"key":"2887_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cca.2018.02.013","volume":"480","author":"MA Raffat","year":"2018","unstructured":"Raffat MA, Hadi NI, Hosein M, Mirza S, Ikram S, Akram Z. S100 proteins in oral squamous cell carcinoma. Clin Chim Acta. 2018;480:143\u20139.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2887_CR37","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1080\/21655979.2021.1974328","volume":"12","author":"Z Huang","year":"2021","unstructured":"Huang Z, Lan T, Wang J, Chen Z, Zhang X. Identification and validation of seven RNA binding protein genes as a prognostic signature in oral cavity squamous cell carcinoma. Bioengineered. 2021;12(1):7248\u201362.","journal-title":"Bioengineered"},{"issue":"7","key":"2887_CR38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.oraloncology.2011.04.024","volume":"47","author":"PH Chen","year":"2011","unstructured":"Chen PH, Lee KW, Chen CH, Shieh TY, Ho PS, Wang SJ, Lee CH, Yang SF, Chen MK, Chiang SL, et al. CYP26B1 is a novel candidate gene for betel quid-related oral squamous cell carcinoma. Oral Oncol. 2011;47(7):594\u2013600.","journal-title":"Oral Oncol"},{"key":"2887_CR39","volume":"2014","author":"PH Chen","year":"2014","unstructured":"Chen PH, Lee KW, Hsu CC, Chen JY, Wang YH, Chen KK, Wang HM, Huang HW, Huang B. Expression of a splice variant of CYP26B1 in betel quid-related oral cancer. ScientificWorldJournal. 2014;2014: 810561.","journal-title":"ScientificWorldJournal"},{"key":"2887_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12935-019-0870-6","volume":"19","author":"MH Pourhanifeh","year":"2019","unstructured":"Pourhanifeh MH, Mohammadi R, Noruzi S, Hosseini SA, Fanoudi S, Mohamadi Y, Hashemzehi M, Asemi Z, Mirzaei HR, Salarinia R, et al. The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy. Cancer Cell Int. 2019;19:157.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"2887_CR41","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1053\/j.gastro.2011.11.029","volume":"142","author":"E Mormone","year":"2012","unstructured":"Mormone E, Lu Y, Ge X, Fiel MI, Nieto N. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice. Gastroenterology. 2012;142(3):612-621 e615.","journal-title":"Gastroenterology"},{"key":"2887_CR42","doi-asserted-by":"publisher","first-page":"78972","DOI":"10.7554\/eLife.78972","volume":"11","author":"S Sengupta","year":"2022","unstructured":"Sengupta S, Mondal M, Prasasvi KR, Mukherjee A, Magod P, Urbach S, Friedmann-Morvinski D, Marin P, Somasundaram K. Differentiated glioma cell-derived fibromodulin activates integrin-dependent Notch signaling in endothelial cells to promote tumor angiogenesis and growth. Elife. 2022;11:78972.","journal-title":"Elife"},{"issue":"3","key":"2887_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.bbrc.2013.06.005","volume":"436","author":"J Jian","year":"2013","unstructured":"Jian J, Zheng Z, Zhang K, Rackohn TM, Hsu C, Levin A, Enjamuri DR, Zhang X, Ting K, Soo C. Fibromodulin promoted in vitro and in vivo angiogenesis. Biochem Biophys Res Commun. 2013;436(3):530\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5839","key":"2887_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.1144090","volume":"317","author":"AS Brack","year":"2007","unstructured":"Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007;317(5839):807\u201310.","journal-title":"Science"},{"key":"2887_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.matbio.2018.03.017","volume":"68\u201369","author":"O Burgy","year":"2018","unstructured":"Burgy O, Konigshoff M. The WNT signaling pathways in wound healing and fibrosis. Matrix Biol. 2018;68\u201369:67\u201380.","journal-title":"Matrix Biol"},{"issue":"6348","key":"2887_CR46","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1126\/science.aal2380","volume":"357","author":"WA Flavahan","year":"2017","unstructured":"Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science. 2017;357(6348):2380.","journal-title":"Science"},{"issue":"11","key":"2887_CR47","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012\u201327.","journal-title":"Trends Genet"},{"issue":"2","key":"2887_CR48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.trecan.2019.12.006","volume":"6","author":"D Roy","year":"2020","unstructured":"Roy D, Tiirikainen M. Diagnostic power of DNA methylation classifiers for early detection of cancer. Trends Cancer. 2020;6(2):78\u201381.","journal-title":"Trends Cancer"},{"issue":"4","key":"2887_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1045","volume":"3","author":"PW Laird","year":"2003","unstructured":"Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer. 2003;3(4):253\u201366.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2887_CR50","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.gastro.2012.10.002","volume":"144","author":"AS Cheng","year":"2013","unstructured":"Cheng AS, Li MS, Kang W, Cheng VY, Chou JL, Lau SS, Go MY, Lee CC, Ling TK, Ng EK, et al. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis. Gastroenterology. 2013;144(1):122-133 e129.","journal-title":"Gastroenterology"},{"key":"2887_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biochi.2018.07.025","volume":"154","author":"A Cianciulli","year":"2018","unstructured":"Cianciulli A, Menga A, Ferdinando P, Iacobazzi V. FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells. Biochimie. 2018;154:25\u201334.","journal-title":"Biochimie"},{"issue":"1","key":"2887_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.cr.7310125","volume":"17","author":"G Pan","year":"2007","unstructured":"Pan G, Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res. 2007;17(1):42\u20139.","journal-title":"Cell Res"},{"issue":"1","key":"2887_CR53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/jhg.2012.119","volume":"58","author":"I Laczmanska","year":"2013","unstructured":"Laczmanska I, Karpinski P, Bebenek M, Sedziak T, Ramsey D, Szmida E, Sasiadek MM. Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer. J Hum Genet. 2013;58(1):11\u20135.","journal-title":"J Hum Genet"},{"key":"2887_CR54","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1038\/srep09633","volume":"5","author":"PR Sudhir","year":"2015","unstructured":"Sudhir PR, Lin ST, Chia-Wen C, Yang SH, Li AF, Lai RH, Wang MJ, Chen YT, Chen CF, Jou YS, et al. Loss of PTPRM associates with the pathogenic development of colorectal adenoma-carcinoma sequence. Sci Rep. 2015;5:9633.","journal-title":"Sci Rep"},{"key":"2887_CR55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13148-017-0363-1","volume":"9","author":"K Misawa","year":"2017","unstructured":"Misawa K, Mochizuki D, Imai A, Misawa Y, Endo S, Mima M, Kawasaki H, Carey TE, Kanazawa T. Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer. Clin Epigenetics. 2017;9:64.","journal-title":"Clin Epigenetics"},{"issue":"11","key":"2887_CR56","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1016\/j.celrep.2018.11.050","volume":"25","author":"ML Ibrahim","year":"2018","unstructured":"Ibrahim ML, Klement JD, Lu C, Redd PS, Xiao W, Yang D, Browning DD, Savage NM, Buckhaults PJ, Morse HC 3rd, et al. Myeloid-derived suppressor cells produce IL-10 to elicit DNMT3b-dependent IRF8 silencing to promote colitis-associated colon tumorigenesis. Cell Rep. 2018;25(11):3036-3046 e3036.","journal-title":"Cell Rep"},{"issue":"3","key":"2887_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017149","volume":"6","author":"M Yamamoto","year":"2011","unstructured":"Yamamoto M, Cid E, Bru S, Yamamoto F. Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers. PLoS ONE. 2011;6(3): e17149.","journal-title":"PLoS ONE"},{"issue":"6","key":"2887_CR58","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/ijc.26136","volume":"130","author":"O Ammerpohl","year":"2012","unstructured":"Ammerpohl O, Pratschke J, Schafmayer C, Haake A, Faber W, von Kampen O, Brosch M, Sipos B, von Schonfels W, Balschun K, et al. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma. Int J Cancer. 2012;130(6):1319\u201328.","journal-title":"Int J Cancer"},{"issue":"30","key":"2887_CR59","doi-asserted-by":"publisher","first-page":"eaba3688","DOI":"10.1126\/sciadv.aba3688","volume":"6","author":"R Dhanwani","year":"2020","unstructured":"Dhanwani R, Takahashi M, Mathews IT, Lenzi C, Romanov A, Watrous JD, Pieters B, Hedrick CC, Benedict CA, Linden J, et al. Cellular sensing of extracellular purine nucleosides triggers an innate IFN-beta response. Sci Adv. 2020;6(30):eaba3688.","journal-title":"Sci Adv"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-02887-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-023-02887-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-02887-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T10:03:06Z","timestamp":1679738586000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-023-02887-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2887"],"URL":"https:\/\/doi.org\/10.1186\/s12903-023-02887-2","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]},"assertion":[{"value":"1 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}